Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)". Circulation. 2019 Jan 15;139(3):416-417 Authors: Koh KK PMID: 30640544 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30640544?dopt=Abstract

Source: Circulation - January 15, 2019 Category: Cardiology Authors: Koh KK Tags: Circulation Source Type: research